Showing results (51-60 of 172) with videos related to
Sort By:
Pageof 18
Anticancer Research|April 22, 2011
Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell linesCao Yang, Edwin Choy, Francis J Hornicek, et al.Pharmaceutical Research|December 18, 2014
Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian CancerXiaoqian Yang, Arun K Iyer, Amit Singh, et al.Cancer Letters|February 11, 2010
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcomaZhenfeng Duan, Diana Ji, Edward J Weinstein, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2010
Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancerYuqi Guo, Jeffrey Nemeth, Colin O'Brien, et al.Oncotarget|November 12, 2016
Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistanceTang Liu, Zhihong Li, Qing Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferationZhenfeng Duan, Jianming Zhang, Edwin Choy, et al.Oncotarget|April 15, 2015
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordomaYong Feng, Jacson Shen, Yan Gao, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 22, 2015
Clinical and biological significance of PIM1 kinase in osteosarcomaYunfei Liao, Yong Feng, Jacson Shen, et al.Carcinogenesis|January 1, 2010
The kinase Mirk is a potential therapeutic target in osteosarcomaCao Yang, Diana Ji, Edward J Weinstein, et al.JACC. Case Reports|January 17, 2025
Atypical Location of Papillary Fibroelastoma in a Patient With Significant Oncologic HistoryAdham Makarem, Patrick Udeh, Carly Liquori, et al.Pageof 18